Latest Funding News

Magnum Mining & Exploration has raised $7 million through an oversubscribed placement to accelerate its critical minerals processing hub in Nevada and expand rare earth exploration in Brazil, aligning with US strategic priorities.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Magnum Mining and Exploration Limited has voluntarily suspended trading of its shares pending a significant capital raise announcement, signaling a pivotal moment for the company.

Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.

Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.

Cedar Woods Properties has activated its Dividend Reinvestment and Bonus Share Plans for the final 2025 dividend, offering shares at a 2.5% discount and backed by full underwriting from major brokers.

Canterbury Resources is on the cusp of completing a pivotal scoping study for its Briggs Copper Project, while deep drilling advances to unlock higher-grade mineralisation. The company also moves forward with new exploration initiatives and a share purchase plan to bolster funding.

AustChina Holdings has received a non-binding proposal from Bluestone Energy to invest $1.5 million via a large share placement, potentially fueling new acquisitions and exploration efforts.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Equity Trustees faces an expanded Federal Court claim from ASIC seeking compensation for superannuation members after a $73 million revaluation hit the Shield Master Fund. The trustee disputes liability and supports liquidation efforts to recover member funds.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.